25 May 2013
Keywords: gilead, oral, flu, drug, nears, trials, sciences
Article | 03 February 1997
Gilead Sciences' oral neuraminidase inhibitor GS 4104 should enter theclinic in the next few months, said the company at a news ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.